Breaking News Instant updates and real-time market news.

VRTX

Vertex

$175.02

0.5 (0.29%)

08:04
08/07/18
08/07
08:04
08/07/18
08:04

Vertex transferred with a Buy at Stifel

Stifel transferred coverage of Vertex to analyst Paul Matteis, who set a Buy rating and $200 price target on the shares. Matteis thinks Vertex continues to build strong barriers to entry that in Cystic Fibrosis and believes that the company's non-CF pipeline largely represents upside to the stock.

  • 30

    Aug

  • 31

    Aug

VRTX Vertex
$175.02

0.5 (0.29%)

07/26/18
PIPR
07/26/18
NO CHANGE
Target $230
PIPR
Overweight
Vertex price target raised to $230 from $212 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Vertex Pharmaceuticals to $230 saying cystic fibrosis sales of $750M in Q2 beat his $668M estimate, driven by strong Symdeko uptake and Orkambi cannibalization. Importantly, TripleRx Phase III enrollment is rapid and Vertex anticipates filing a new drug application on the best regimen in mid-2019 with approval likely in 2020, Tenthoff tells investors in a post-earnings research note. He reiterates an Overweight rating on the shares.
07/26/18
OPCO
07/26/18
NO CHANGE
Target $200
OPCO
Outperform
Vertex price target raised to $200 from $180 at Oppenheimer
Oppenheimer analyst Hartaj Singh raised his price target for Vertex to $200 from $180 on "robust" Q2 results and accelerating pipeline. The analyst reiterates an Outperform rating on the shares.
07/26/18
BMOC
07/26/18
NO CHANGE
Target $204
BMOC
Outperform
Vertex price target raised to $204 from $191 at BMO Capital
BMO Capital analyst Do Kim raised his price target on Vertex to $204 and kept his Outperform rating after "stellar" Q2 results that "easily" beat consensus due to the strong Symdeko sales. The analyst notes that Symdeko appears to be "capturing Orkambi switchers as well as naive patients and Orkambi dropouts", adding that its updated revenue guidance is likely to prove conservative on Symdeko's expansion potential.
07/27/18
PIPR
07/27/18
NO CHANGE
Target $230
PIPR
Overweight
Piper says Vertex faces 'onerous task' getting reimbursement for Symkevi in EU
After the EMA announced earlier that the CHMP adopted a positive opinion on Symkevi, Piper Jaffray analyst Edward Tenthoff said he expects EMA approval within the next few months, after which Vertex will face the "onerous task" of gaining European reimbursement. The analyst, who anticipates KALYDECO and ORKAMBI label expansions with PDUFA dates in August to continue to drive CF sales growth this year, keeps his Overweight rating and $230 price target on Vertex shares.

TODAY'S FREE FLY STORIES

PDD

Pinduoduo

$23.78

0.63 (2.72%)

15:30
11/21/18
11/21
15:30
11/21/18
15:30
Options
Put sellers in Pinduoduo as shares extend gains »

Put sellers in Pinduoduo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$177.75

0.65 (0.37%)

, AMZN

Amazon.com

$1,523.71

28.11 (1.88%)

15:29
11/21/18
11/21
15:29
11/21/18
15:29
Periodicals
Apple weighed new connected TV 'dongle,' Information reports »

Apple (AAPL) has held…

AAPL

Apple

$177.75

0.65 (0.37%)

AMZN

Amazon.com

$1,523.71

28.11 (1.88%)

GOOG

Alphabet

$1,044.26

18.26 (1.78%)

GOOGL

Alphabet Class A

$1,050.29

19.07 (1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 04

    Dec

  • 04

    Dec

  • 03

    Mar

TSRO

Tesaro

$43.63

1.15 (2.71%)

15:25
11/21/18
11/21
15:25
11/21/18
15:25
Options
TESARO call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

GME

GameStop

$13.72

1.42 (11.54%)

15:22
11/21/18
11/21
15:22
11/21/18
15:22
Recommendations
GameStop analyst commentary  »

GameStop sale of Spring…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

ESRX

Express Scripts

$95.91

0.61 (0.64%)

, CI

Cigna

$210.99

3.09 (1.49%)

15:18
11/21/18
11/21
15:18
11/21/18
15:18
Hot Stocks
NYDFS to hold hearing on Cigna deal for Express Scripts on December 7 »

The New York State…

ESRX

Express Scripts

$95.91

0.61 (0.64%)

CI

Cigna

$210.99

3.09 (1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
11/21/18
11/21
15:17
11/21/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
11/21/18
11/21
15:16
11/21/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUS

Nu Skin

$66.17

0.75 (1.15%)

15:14
11/21/18
11/21
15:14
11/21/18
15:14
Recommendations
Nu Skin analyst commentary  »

Nu Skin pullback a buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QD

Qudian

$5.38

1.08 (25.12%)

15:10
11/21/18
11/21
15:10
11/21/18
15:10
Options
Call buyers in Qudian as shares rally 24% »

Call buyers in Qudian as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

HDSN

Hudson Technologies

$1.13

0.04 (3.67%)

15:04
11/21/18
11/21
15:04
11/21/18
15:04
Options
Hudson Technologies options imply 31.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABX

Barrick Gold

$13.52

0.5 (3.84%)

15:00
11/21/18
11/21
15:00
11/21/18
15:00
Options
Size Reverse/Conversion trade in Barrick Gold suggests stock replacement »

Size Reverse/Conversion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OIH

Oil Services Holders Trust

$18.87

0.37 (2.00%)

14:50
11/21/18
11/21
14:50
11/21/18
14:50
Options
Active trading in VanEck Vectors Oil Services 20-strike calls »

Active trading in VanEck…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,529.99

34.39 (2.30%)

14:50
11/21/18
11/21
14:50
11/21/18
14:50
Periodicals
NYC officials say half of Queens Amazon jobs won't be in tech, WSJ says »

New York City officials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 04

    Dec

SQM

SQM

$43.70

1.825 (4.36%)

14:49
11/21/18
11/21
14:49
11/21/18
14:49
Options
SQM options imply 8.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:45
11/21/18
11/21
14:45
11/21/18
14:45
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

CBFV

CB Financial Services

$25.79

(0.00%)

14:42
11/21/18
11/21
14:42
11/21/18
14:42
Hot Stocks
CB Financial Services increases dividend by 4.5% to 23c per share »

CB Financial Services,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BECN

Beacon Roofing

$32.94

4.87 (17.35%)

14:28
11/21/18
11/21
14:28
11/21/18
14:28
Hot Stocks
CD&R Group to buy additional shares in Beacon Roofing »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

NTN

NTN Buzztime

$2.70

-0.1 (-3.57%)

14:26
11/21/18
11/21
14:26
11/21/18
14:26
Hot Stocks
Northstar reports 10.33% stake in NTN Buzztime »

On November 21, Northstar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:23
11/21/18
11/21
14:23
11/21/18
14:23
Conference/Events
The U.S. Commodity Futures Trading Commission to hold a podcast »

The Commodity Futures…

RHHBY

Roche

$0.00

(0.00%)

, ABBV

AbbVie

$85.75

-2.35 (-2.67%)

14:18
11/21/18
11/21
14:18
11/21/18
14:18
Hot Stocks
Roche announces FDA grants accelerated approval for Venclexta combo »

Roche (RHHBY) announced…

RHHBY

Roche

$0.00

(0.00%)

ABBV

AbbVie

$85.75

-2.35 (-2.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

  • 03

    Dec

  • 24

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
11/21/18
11/21
14:17
11/21/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$85.70

-2.4 (-2.72%)

, RHHBY

Roche

$0.00

(0.00%)

14:16
11/21/18
11/21
14:16
11/21/18
14:16
Hot Stocks
AbbVie says FDA grants accelerated approval to Venclexta-azacitidine combo »

AbbVie (ABBV) announced…

ABBV

AbbVie

$85.70

-2.4 (-2.72%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

  • 03

    Dec

  • 24

    Dec

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
11/21/18
11/21
14:16
11/21/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPP

WPP

$54.99

1.4 (2.61%)

14:15
11/21/18
11/21
14:15
11/21/18
14:15
Periodicals
Martin Sorrell to poach senior executive from WPP, Sky News reports »

Martin Sorrell is to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

TGT

Target

$69.10

0.05 (0.07%)

14:10
11/21/18
11/21
14:10
11/21/18
14:10
Options
Target calls lead puts 3:1 after a big drop in shares »

Target calls lead puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.